Delivery Order SPE2DB20D2002-SPE2DB25FL16Y
- Not listed
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside designation and was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,050.90 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a anticoagulant medication commonly used in military and veteran healthcare settings. The award, issued on September 18, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 19, 2025. This non-compete, competitively awarded order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,017.91 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award conditions. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,215.38 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, an anticoagulant medication commonly used in military and veteran healthcare settings. The contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. Performance will be fulfilled at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. The award, made on September 4, 2025, with completion targeted for September 5, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award status. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $6,133.96 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count packages), with an ultimate completion date of August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) vehicle—specifically the DLA Troop Support Medical SPE2DX prime vendor contract valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging). This firm fixed-price contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is non-set-aside and was competitively awarded, with a place of performance in Conshohocken,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL16YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a anticoagulant medication commonly used in military and veteran healthcare systems. This competitively awarded, firm fixed-price delivery order was issued on January 30, 2025, with an ultimate completion date of January 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp leverages its comprehensive IDC vehicle to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The prime IDV enables the company to serve various government healthcare entities including the Defense Health Agency and U.S. Coast Guard. This delivery order for Eliquis exemplifies the company's role as a critical vendor within the Defense Logistics Agency's medical supply chain, fulfilling on-demand pharmaceutical requirements through a flexible and competitively structured contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/30/25 |